Releases
Found 20945 articles
L'Oréal and Louis Theroux Headline UNLEASH Paris HR Summit
With 8,500 senior leaders representing 100 million global employees converging on the Paris Convention Centre from October 20–22, 2026, the UNLEASH conference marks a definitive shift toward AI-driven organizational design, moving beyond automation to embrace a new category of enterprise-wide work technology.
Shareholders Urged to Join Securities Fraud Suit Against Phreesia
Investors who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is spearheading the litigation, alleging the company misled the market regarding its long-term growth projections and revenue reliability for fiscal year 2027.
Investors Launch Class Action Against Zoetis Over Misleading Claims
A federal class action lawsuit has been filed against animal health giant Zoetis Inc., alleging that the company misled shareholders regarding the performance and market challenges of key product lines. The litigation centers on potential violations of the Securities Exchange Act during an sixteen-month period ending in May 2026.
Verra Mobility Faces Class Action Over Misleading Market Statements
Investors who purchased Verra Mobility Corporation stock between February 24 and May 26, 2026, are being urged to join a class action lawsuit. The litigation alleges the company misled shareholders regarding the stability of its rental car industry partnerships, specifically concerning the loss of a major client.
Roblox Faces Securities Lawsuit Over Misleading Growth Claims
Investors who purchased Roblox Corporation stock between October 30, 2025, and April 30, 2026, are now the target of a class action lawsuit alleging violations of the Securities Exchange Act. The complaint centers on claims that the gaming company obscured the negative impact of new age-verification protocols on its growth.
Phreesia Faces Class Action Lawsuit Over Alleged Misleading Growth Claims
Investors who purchased Phreesia, Inc. stock between May 8, 2025, and March 30, 2026, face a July 13 deadline to join a class action lawsuit. The litigation alleges the company misled shareholders by projecting reliable fiscal year 2027 growth despite underlying industry volatility that threatened its core revenue streams.
Schall Law Firm Targets PicS N.V. Over Alleged IPO Misconduct
Investors who purchased PicS N.V. securities following the company’s January 30, 2026, initial public offering now have until August 4 to join a class action lawsuit. The Schall Law Firm alleges the company misled shareholders by overstating the quality of its underwriting practices and concealing significant financial risks.
ALZpath Antibody Anchors Alzheimer’s Research at AAIC 2026
Eighty-six scientific presentations at this year's Alzheimer's Association International Conference in London highlight the role of ALZpath’s proprietary pTau217 antibody. As blood-based testing gains momentum, the company’s diagnostic tool has become a critical standard for academic and clinical research programs aiming to detect amyloid pathology earlier.
AutoShop Answers Taps Industry Veteran George Zeeks for Growth Role
George Zeeks, a veteran with two decades of experience in the automotive aftermarket, has been appointed Vice President of Growth & Development at AutoShop Answers. The Houston-based company, a division of the Houston Boston Partnership, is leveraging the hire to accelerate its national expansion and leadership development services.
Lighthouse Pharmaceuticals Links Gingipain Inhibition to Behavioral Gains
Forty-eight weeks of treatment with the gingipain inhibitor atuzaginstat significantly curbed agitation, aggression, and caregiver distress in patients testing positive for Porphyromonas gingivalis. These findings, presented at the Alzheimer’s Association International Conference 2026, suggest a potential path to managing the most taxing behavioral symptoms of the disease.
Eisai’s Etalanetug Shows Promise in Targeting Alzheimer’s Tau Pathology
Experimental anti-tau antibody etalanetug significantly reduced levels of the plasma biomarker eMTBR-tau243 in patients with dominantly inherited Alzheimer’s disease, according to new data presented at the 2026 Alzheimer’s Association International Conference in London. The findings suggest a potential shift toward less invasive diagnostic and monitoring tools for the neurodegenerative condition.
Zoetis Investors Face Class Action Lawsuit Over Alleged Market Misleading
Investors who held shares in Zoetis Inc. between January 14, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on claims that the pharmaceutical company issued false statements regarding its core veterinary product performance.
The Leela Named World's Second-Best Hotel Brand in 2026 T+L Rankings
Voters in the 2026 Travel + Leisure World's Best Awards have propelled The Leela Palaces, Hotels and Resorts to the second spot globally, cementing the Indian chain's standing among the elite of international luxury hospitality as it marks four decades of operation.
Schall Law Firm Targets Genius Group Over Alleged Spoofing Scheme
Investors who held Genius Group Limited stock between April 2022 and May 2025 face a critical window to join a pending class action lawsuit. The Schall Law Firm alleges the company misled shareholders through a market manipulation scheme, artificially inflating trading activity to mask the firm's true financial standing.
Hub Group Faces Class Action Over Financial Reporting Discrepancies
Investors who purchased Hub Group, Inc. securities between April 28, 2023, and May 11, 2026, are being urged to join a class action lawsuit. The Schall Law Firm alleges the logistics company misled the market by issuing false financial statements regarding its revenue, income, and transportation costs throughout the designated period.
Investors Targeted in Futu Holdings Securities Fraud Class Action
A federal class action lawsuit now invites shareholders to hold Futu Holdings Limited accountable for alleged securities fraud. The Schall Law Firm is spearheading the litigation, targeting claims that the company misled investors regarding its regulatory compliance status in China between May 2023 and May 2026.
Nammos to Open Luxury Resort and Residences on Montenegro’s Coast
Ten minutes from the iconic islet of Sveti Stefan, a new luxury destination is taking shape on the Budva Riviera. Nammos Hotels & Resorts and Smokva Bay have announced a partnership to develop an integrated resort, branded villas, and a retail village, marking the brand’s entry into the Montenegrin market.
Nammos and Smokva Bay to Develop Luxury Adriatic Resort in Montenegro
Ten minutes from the iconic Sveti Stefan, a new luxury destination is taking shape on the Budva Riviera. Nammos Hotels & Resorts and developer Smokva Bay have finalized plans for a 117-key integrated resort, marking the brand’s first major expansion into the Montenegrin coast with a targeted opening in 2029.
Nammos Resort Montenegro Set to Transform Budva Riviera by 2029
Ten minutes from the iconic Sveti Stefan, a new luxury destination is taking shape on the Montenegrin coast as Nammos Hotels & Resorts joins forces with Smokva Bay. The project, slated for completion in 2029, aims to blend high-end Mediterranean hospitality with a sprawling, integrated lifestyle complex along the Budva Riviera.
Investors Targeted in GRAIL Securities Class Action Lawsuit
Shareholders who purchased GRAIL, Inc. stock between May 13, 2025, and February 19, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is seeking participants for litigation alleging the company misled the market regarding the efficacy and timeline of its NHS-Galleri cancer trial.
Investors Target Insulet Corporation in Securities Fraud Class Action
Shareholders who acquired Insulet Corporation stock between February 21, 2025, and May 26, 2026, are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on allegations that the company misled investors regarding manufacturing defects and safety oversight failures.
Schall Law Firm Targets ZoomInfo Over Alleged Misleading Growth Claims
Investors who purchased ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, face a critical deadline to join a class action lawsuit. The Schall Law Firm is seeking participants for the litigation, which alleges the company misled the market regarding its actual demand and growth trajectory.
Gentoo Media Taps Former Raketech CFO Måns Svalborn for Financial Lead
With over two decades of financial leadership, Måns Svalborn is set to join Gentoo Media as Chief Financial Officer this October. His appointment marks a strategic move for the Malta-based affiliate giant as it seeks to bolster its executive team and continue its expansion in the global iGaming market.
AeroVironment Investors Targeted in Securities Fraud Class Action
Investors who held AeroVironment, Inc. stock between June 25, 2025, and March 10, 2026, face a critical deadline as The Schall Law Firm initiates a class action lawsuit. The litigation centers on allegations that the company misled shareholders regarding competitive threats to its U.S. Space Force SCAR program contract.
Tomocube Debuts HT-T1D for 3D Glass Substrate Defect Analysis
Daejeon-based Tomocube has unveiled the HT-T1 Desktop, a holotomography system designed to identify internal micro-defects within glass substrates. By transitioning from destructive testing to non-destructive 3D visualization, the company aims to help semiconductor manufacturers accelerate yield learning and stabilize production lines for next-generation advanced packaging applications.
Egardia Launches Wholesale Platform to Fast-Track Telecom Security Services
Telecom operators have long struggled to move beyond basic connectivity, often deterred by the steep costs and technical complexity of building home security infrastructure from scratch. Egardia is now aiming to bridge this gap, launching a wholesale platform that allows providers to roll out branded, subscription-based security services.
Investors Eye Class Action Against Badger Meter Over Revenue Claims
Shareholders who acquired Badger Meter stock between April 18, 2024, and April 16, 2026, face a potential class action lawsuit alleging securities fraud. The Schall Law Firm is currently organizing the litigation, claiming the company misled the market regarding the true nature of its financial growth and revenue recognition practices.
Schall Law Firm Targets Calix Over Alleged Securities Violations
Investors who purchased Calix, Inc. securities between January 28 and April 21, 2026, face a critical deadline to join a pending class action lawsuit. The Schall Law Firm is representing shareholders alleging the company issued false and misleading statements regarding its margin performance and supply chain stability during the specified class period.
BitGo Faces Securities Class Action Over Alleged IPO Misstatements
Investors who purchased BitGo Holdings securities between January 2025 and May 2026 are being urged to join a class action lawsuit filed by The Schall Law Firm. The litigation centers on claims that the company misled the market regarding its financial health and the risks posed by fluctuating digital asset prices.
Investors Target Black Rock Coffee Bar Over Alleged Securities Fraud
The Schall Law Firm has launched a class action lawsuit against Black Rock Coffee Bar, Inc., alleging the company misled shareholders regarding its growth strategy. Investors who purchased BRCB stock between September 12, 2025, and May 12, 2026, are being urged to seek legal counsel before the August 17 deadline.